In ovarian cancer, an NSUN2/IGF2 signature has been identified, which has prognostic survival value, as patients with high NSUN2 expression and low IGF-II expression had significantly superior overall and disease progression-free survival [117]. This evidence concerns the gene IGF2 and ovarian carcinoma.